Mart Ustav Jr | Chief Scientific Officer
Icosagen Cell Factory
Mart Ustav Jr. is the Chief Scientific Officer at Icosagen Group. During his postdoctoral research at the University of Toronto, he developed innovative antibody engineering platforms, including a novel Virus-Like Particle system for membrane protein display, which has opened new possibilities in therapeutic antibody discovery. His work has led to successful collaborations with leading pharmaceutical companies and has resulting in multiple patents. At Icosagen, he continues to lead cutting-edge R&D efforts in antibody based therapeutics and antibody, pushing the boundaries of molecular biology and therapeutic innovation.
Appearances:
Festival of Biologics Day 2 @ 14:50
Designing Manufacturability into Multispecifics Early: How Integrated CRDMO De-risks Biologics Programs and Accelerates Development
- Development of complex biologics is often slowed by late-stage discovery of manufacturability and developability challenges.
- We present a CRDMO-based approach that combines transient expression, early process development, and analytical characterization to generate critical knowledge before final candidate selection.
- Using case study comparing transient and stable production material, we demonstrate how earlier assessment of manufacturability risks can support faster, lower-risk, and more cost-effective development pathways.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events